A novel role for 14-3-3σ in regulating epithelial cell polarity

Genes and Development

Volumn 24, Issue 9, 2010, Pages 947-956

  Ling, Chen ^a,b   Zuo, Dongmei ^a,b   Xue, Bin ^c,d   Muthuswamy, Senthil ^c,d,e   Muller, William J ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c Simons Center for Quantitative Biology   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF TORONTO   (Canada)

Author keywords

14 3 3 ; Conditional knockout; Epithelial polarity; ErbB2

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST TUMOR; CELL POLARITY; CELL PROLIFERATION; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; GENE DELETION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION;

14-3-3 PROTEINS; ANIMALS; CELL LINE, TUMOR; CELL POLARITY; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; INTERCELLULAR JUNCTIONS; MAMMARY GLANDS, ANIMAL; MICE; MICE, KNOCKOUT;

MUS MUSCULUS;

EID: 77951781454     PISSN: 08909369     EISSN: 15495477     Source Type: Journal    
DOI: 10.1101/gad.1896810     Document Type: Article

References (34)

1. Andrechek ER, Hardy WR, Siegel PM, Rudnicki MA, Cardiff RD, Muller WJ. 2000. Amplification of the neu/erbB-2 oncogene in a mouse model of mammary tumorigenesis. Proc Natl Acad Sci 97: 3444-3449.
2. Andrechek ER, Laing MA, Girgis-Gabardo AA, Siegel PM, Cardiff RD, Muller WJ. 2003. Gene expression profiling of neu-induced mammary tumors from transgenic mice reveals genetic and morphological similarities to ErbB2-expressing human breast cancers. Cancer Res 63: 4920-4926.
3. Andrulis I, Bull S, Blackstein M, Sutherland D, Mak C, Sidlofsky S, Pritzker K, Hartwick R, Hanna W, Lickley L, et al. 1998. neu/erbB-2 amplification identifies a poor-prognosis group of women with node-negative breast cancer. Toronto Breast Cancer Study Group. J Clin Oncol 16: 1340-1349.
4. Aranda V, Haire T, Nolan ME, Calarco JP, Rosenberg AZ, Fawcett JP, Pawson T, Muthuswamy SK. 2006. Par6-aPKC uncouples ErbB2 induced disruption of polarized epithelial organization from proliferation control. Nat Cell Biol 8: 1235-1245. (Pubitemid 44660588)
5. Benton R, Johnston DS. 2003. Drosophila PAR-1 and 14-3-3 inhibit Bazooka/PAR-3 to establish complementary cortical domains in polarized cells. Cell 115: 691-704. (Pubitemid 38030298)
6. Benzinger A, Muster N, Koch HB, Yates JR III, Hermeking H. 2005. Targeted proteomic analysis of 14-3-3ς, a p53 effector commonly silenced in cancer. Mol Cell Proteomics 4: 785-795. (Pubitemid 40873007)
7. Chan TA, Hermeking H, Lengauer C, Kinzler KW, Vogelstein B. 1999. 14-3-3σ is required to prevent mitotic catastrophe after DNA damage. Nature 401: 616-620. (Pubitemid 129517080)
8. Dillon RL, Brown ST, Ling C, Shioda T, Muller WJ. 2007. An EGR2/CITED1 transcription factor complex and the 14-3-3σ tumor suppressor are involved in regulating ErbB2 expression in a transgenic-mouse model of human breast cancer. Mol Cell Biol 27: 8648-8657.
9. Dillon RL, Marcotte R, Hennessy BT, Woodgett JR, Mills GB, Muller WJ. 2009. Akt1 and Akt2 play distinct roles in the initiation and metastatic phases of mammary tumor progression. Cancer Res 69: 5057-5064.
10. Ferguson AT, Evron E, Umbricht CB, Pandita TK, Chan TA, Hermeking H, Marks JR, Lambers AR, Futreal PA, Stampfer MR, et al. 2000. High frequency of hypermethylation at the 14-3-3σ locus leads to gene silencing in breast cancer. Proc Natl Acad Sci 97: 6049-6054. (Pubitemid 30367521)
11. Genuardi M, Tsihira H, Anderson DE, Saunders GF. 1989. Distal deletion of chromosome Ip in ductal carcinoma of the breast. Am J Hum Genet 45: 73-82. (Pubitemid 19178523)
12. Hermeking H, Lengauer C, Polyak K, He T-C, Zhang L, Thiagalingam S, Kinzler KW, Vogelstein B. 1997. 14-3-3σ is a p53-regulated inhibitor of G2/M progression. Mol Cell 1: 3-11. (Pubitemid 127376388)
13. Herron BJ, Liddell RA, Parker A, Grant S, Kinne J, Fisher JK, Siracusa LD. 2005. A mutation in stratifin is responsible for the repeated epilation (Er) phenotype in mice. Nat Genet 37: 1210-1212. (Pubitemid 41568702)
14. Hodgson JG, Malek T, Bornstein S, Hariono S, Ginzinger DG, Muller WJ, Gray JW. 2005. Copy number aberrations in mouse breast tumors reveal loci and genes important in tumorigenic receptor tyrosine kinase signaling. Cancer Res 65: 9695-9704. (Pubitemid 41541445)
15. Hurd TW, Fan S, Liu C-J, Kweon HK, Hakansson K, Margolis B. 2003. Phosphorylation-dependent binding of 14-3-3 to the polarity protein Par3 regulates cell polarity in mammalian epithelia. Curr Biol 13: 2082-2090. (Pubitemid 37502525)
16. Hynes NE, Stern DF. 1994. The biology of erbB-2/nue/HER-2 and its role in cancer. Biochim Biophys Acta 1198: 165-184.
17. Kauraniemi P, Barlund M, Monni O, Kallioniemi A. 2001. New amplified and highly expressed genes discovered in the ERBB2 amplicon in breast cancer by cDNA microarrays. Cancer Res 61: 8235-8240. (Pubitemid 33091617)
18. Khoury H, Naujokas MA, Zuo D, Sangwan V, Frigault MM, Petkiewicz S, Dankort DL, Muller WJ, Park M. 2005. HGF converts ErbB2/Neu epithelial morphogenesis to cell invasion. Mol Biol Cell 16: 550-561. (Pubitemid 40165554)
19. Laronga C, Yang H-Y, Neal C, Lee M-H. 2000. Association of the cyclin-dependent kinases and 14-3-3σ negatively regulates cell cycle progression. J Biol Chem 275: 23106-23112. (Pubitemid 30646202)
20. Li Q, Lu Q, Estepa G, Verma IM. 2005. Identification of 14-3-3σ mutation causing cutaneous abnormality in repeated-epilation mutant mouse. Proc Natl Acad Sci 102: 15977-15982. (Pubitemid 41552853)
21. Lu J, Guo H, Treekitkarnmongkol W, Li P, Zhang J, Shi B, Ling C, Zhou X, Chen T, Chiao PJ, et al. 2009. 14-3-3ζ cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell 16: 195-207.
22. McCaffrey LM, Macara IG. 2009. The Par3/aPKC interaction is essential for end bud remodeling and progenitor differentiation during mammary gland morphogenesis. Genes & Dev 23: 1450-1460.
23. Montagna C, Andrechek ER, Padilla-Nash H, Muller WJ, Ried T. 2002. Centrosome abnormalities, recurring deletions of chromosome 4, and genomic amplification of HER2/neu define mouse mammary gland adenocarcinomas induced by mutant HER2/neu. Oncogene 21: 890-898. (Pubitemid 34146302)
24. Muthuswamy SK, Li D, Lelievre S, Bissell MJ, Brugge JS. 2001. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol 3: 785-792. (Pubitemid 32842683)
25. Ravdin PM, Chamness GC. 1995. The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: A paradigm for the development of other macromolecular markers - A review. Gene 159: 19-27.
26. Siegel PM, Ryan ED, Cardiff RD, Muller WJ. 1999. Elevated expression of activated forms of Neu/ErbB-2 and ErbB-3 are involved in the induction of mammary tumors in transgenic mice: Implications for human breast cancer. EMBO J 18: 2149-2164.
27. Slamon D, Clark G, Wong S, Levin W, Ullrich A, McGuire W. 1987. Human breast cancer: Correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235: 177-182. (Pubitemid 17231334)
28. Slamon D, Godolphin W, Jones L, Holt J,Wong S, Keith D, Levin W, Stuart S, Udove J, Ullrich A, et al. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244: 707-712. (Pubitemid 19147683)
29. Tsukamoto K, Ito N, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nakamura Y, Emi M. 1998. Allelic loss on chromosome 1p is associated with progression and lymph node metastasis of primary breast carcinoma. Cancer 82: 317-322. (Pubitemid 28060248)
30. Vercoutter-Edouart A-S, Lemoine J, Le Bourhis X, Louis H, Boilly B, Nurcombe V, Revillion F, Peyrat J-P, Hondermarck H. 2001. Proteomic analysis reveals that 14-3-3σ is downregulated in human breast cancer cells. Cancer Res 61: 76-80. (Pubitemid 32095703)
31. Wilker EW, van Vugt MATM, Artim SC, Huang PH, Petersen CP, Reinhardt HC, Feng Y, Sharp PA, Sonenberg N, White FM, et al. 2007. 14-3-3σ controls mitotic translation to facilitate cytokinesis. Nature 446: 329-332. (Pubitemid 46426148)
32. Xin Y, Lu Q, Li Q. 2010. 14-3-3σ controls corneal epithelial cell proliferation and differentiation through the Notch signaling pathway. Biochem Biophys Res Commun 392: 593-598.
33. Yang H, Wen Y-Y, Zhao R, Lin Y-L, Fournier K, Yang H-Y, Qiu Y, Diaz J, Laronga C, Lee M-H. 2006. DNA damage-induced protein 14-3-3 σ inhibits protein kinase B/Akt activation and suppresses Akt-activated cancer. Cancer Res 66: 3096-3105.
34. Zhan L, Rosenberg A, Bergami KC, Yu M, Xuan Z, Jaffe AB, Allred C, Muthuswamy SK. 2008. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135: 865-878.